The insurance industry, which has elevated "thought leadership", "ecosystem disruption" and "value-add synergies", should ...
DBV will also present the clinical trial design of its recently initiated THRIVE study, which will assess the efficacy and safety of the VIASKIN® Peanut Patch in achieving ad lib consumption of ...
Background The Forrester classification remains a cornerstone for assessing haemodynamic status in heart failure, yet its ...
HDV-Insulin Lispro (HDV-LIS) met A1C non-inferiority at Weeks 12 and 25, confirming comparable glycemic control to insulin lispro (LIS) with point-estimate differences below FDA-required 0.1% ...
Researchers from the University of Phoenix College of Doctoral Studies have published new peer-reviewed research examining graduate students' attitudes toward artificial intelligence (AI) chatbots and ...
Opinion
4dOpinion
Trump’s justice department is weaponizing civil rights laws against students of color
Claims of discrimination at UCLA and Yale show how laws meant to foster inclusion are being used for the opposite ...
A new meta-analysis found no statistically significant difference in positive affect, negative affect, or life satisfaction ...
The AUA 2026 conference featured practice-changing abstracts in the field of urologic oncology. Urologists from Fox Chase ...
Higher rates of adverse events offset the positive survival results in an area of great unmet need. For decades, the standard ...
CHICAGO -- Men with metastatic castration-sensitive prostate cancer (mCSPC) and DNA repair alterations had significantly ...
Durvalumab monotherapy did not meet the prespecified statistical threshold for DFS versus active monitoring, despite a 6-point absolute 3-year DFS difference (78% vs 72%). RAMPART enrolled ...
The trial missed its primary endpoint but showed the test can detect cancers earlier, fueling questions around the best framework to evaluate MCED tests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results